Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.1900
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Bio Essence Revenue
Bio Essence had revenue of $794.71K in the quarter ending June 30, 2026, with 206.69% growth. This brings the company's revenue in the last twelve months to $2.91M, up 416.63% year-over-year. In the year 2025, Bio Essence had annual revenue of $1.90M with 485.78% growth.
Revenue (ttm)
2.91M
Revenue Growth
+416.63%
P/S Ratio
3.51
Revenue / Employee
727.88K
Employees
4
Market Cap
10.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.90M | 1.57M | 485.78% |
| Dec 31, 2024 | 323.94K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 621.59K | -266.39K | -30.00% |
| Dec 31, 2021 | 887.98K | -70.72K | -7.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Eagle Pharmaceuticals | 257.55M |
| Earth Science Tech | 35.96M |
| Cannabis Strategic Ventures | 14.60M |
| CV Sciences | 12.74M |
| CordovaCann | 9.83M |
| Healthy Extracts | 6.29M |
| Panacea Life Sciences Holdings | 2.76M |
| Indo Global Exchange(s) PTE | 3.49K |
Bio Essence News
- 4 months ago - Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio - Accesswire
- 6 months ago - BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026 - Accesswire